Are Lloyds Banking Group PLC, GlaxoSmithKline plc And Old Mutual plc The Dividends To Watch In 2016?

The cash looks attractive at Lloyds Banking Group PLC (LON: LLOY), GlaxoSmithKline plc (LON: GSK) and Old Mutual plc (LON: OML).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

At 71.5p today, I reckon Lloyds Banking Group (LSE: LLOY) shares are cheap. For one thing, although there’s no real growth in earnings forecast for this year and next, the bank has been doing just fine in beefing up its liquidity measures and has comfortably passed the Bank of England’s most recent stress tests – and that’s taken a fair bit of capital investment.

But even after that, we’re looking at an estimated P/E of a tiny 8.4 this year, rising to only around 9 next year as EPS is expected to drop back a little. But what really seals it for me is Lloyds’ impressive return to paying dividends. After getting the nod from the BoE to pay out some cash last year, there’s a yield of 3.3% on the cards this year. The interim payment of 0.75p per share was modest, but equalled 2014’s full-year payment, and the firm said it is targeting a “dividend payout ratio of at least 50 per cent of sustainable earnings“. That supports the City’s forecast for a yield of better than 5% next year, which would be just over twice covered by forecast earnings.

Full-year results are expected on 25 February, and a confirmation of the dividend could provide a boost to confidence.

Pharma growth?

I reckon 2016 will be a key year for GlaxoSmithKline (LSE: GSK) dividends too, not because I’m expecting a rise – we’re already looking at huge yields – but because it should be the year that tells us whether it’s going to be sustainable.

Currently the analysts are predicting a pumped-up yield of 7% this year on a share price of 1,350p, but that wouldn’t be anywhere near covered by forecast earnings. Glaxo is making its dividend payments from its cash reserves while it’s in its critical drugs pipeline turnaround phase. We’ve seen three years of falling EPS with a pretty big drop of 20% expected this year, but it was always going to take around three years or more to get the pharmaceuticals giant back to earnings growth.

That growth is predicted to happen in 2016 with an 11% rise on the cards and coupled with a small expected fall in the dividend, we’d see the yield drop to a still-impressive 6.2%. The crucial point is that it would be just about covered by earnings and that, I think, is going to be the determinant of the firm’s dividend policy in the near future. If the return to growth comes off, the payout should hopefully be safe, but if earnings falter for another year, I wouldn’t bank on it.

Resurgent insurance

I’m turning to insurance next, because I think it’s possibly the FTSE 100‘s most undervalued sector. I’ve gone for Aviva shares myself, but today I’m looking at Old Mutual (LSE: OML) because its share price has dropped alarmingly of late – since the start of December we’ve seen a 21% drop to 176p!

But there’s really nothing wrong, and the firm’s third quarter update looked pretty good with record quarterly sales, a net client inflow and funds under management stable at around £320bn. “This has been a very good quarter for the Group,” enthused finance director Ingrid Johnson, and it’s hard to disagree.

It seems the punters are just wary of Old Mutual’s geographic diversity and are running scared from emerging markets these days. But for those made of sterner stuff it leaves well-covered forecast dividend yields of 4.7% and 5% this year and next, from shares on a P/E of only around 8 to 8.5.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alan Oscroft owns shares in Lloyds Banking group and Aviva. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Here’s the best-performing FTSE 100 stock of the last 10 years

Private equity firm 3i has outperformed the rest of the FTSE 100 over the last 10 years. And its big…

Read more »

Fans of Warren Buffett taking his photo
Investing Articles

Here’s why Warren Buffett is selling shares (and why I’m not)

Warren Buffett cited tax considerations as his reason for selling shares in Apple. But this isn’t something most UK investors…

Read more »

Investing Articles

What on earth is going on with the AstraZeneca share price?

The AstraZeneca share price has fallen 30% from its peak in August. Dr James Fox explains what’s going on with…

Read more »

Investing Articles

2 high-yield FTSE 100 shares I’d consider buying for passive income…and one I’d avoid

Some FTSE 100 stocks have eye-popping dividend yields. But will the passive income actually be dished out? Paul Summers takes…

Read more »

Smart young brown businesswoman working from home on a laptop
Investing Articles

These 2 former stock market darlings are trying my patience! Time to sell?

Harvey Jones thought he was getting a bargain when he snapped up these too much-loved FTSE 100 dividend growth stocks.…

Read more »

Investing Articles

Here’s how I’d use £3,000 to target a second income that grows each year

Our writer explains the approach he'd take to trying to build a second income that gets bigger over time, by…

Read more »

Elevated view over city of London skyline
Investing Articles

Is it time to buy this incredible FTSE dividend share?

Christopher Ruane examines one FTSE 100 share with a phenomenal dividend history. Does a steep share price fall this year…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

This FTSE 100 share has just crashed another 20%. Its P/E is now just 9.9 so should I buy?

Harvey Jones was tempted to buy this FTSE 100 share after it crashed in October. Now it's crashed again, it…

Read more »